AstraZeneca Plc won dismissal of a lawsuit in which it was accused of backing out of a deal with Verus Pharmaceuticals Inc. to develop a children’s asthma drug and instead aligning with competitor Map Pharmaceuticals Inc.
AstraZeneca Wins Dismissal of Verus Suit Over Plan to Develop Asthma Drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment